Dr Reddy’s Laboratories has launched moxifloxacin hydrochloride tablets, 400 mg, a therapeutic equivalent generic version of Avelox (moxifloxacin HCl) tablets 400 mg in the US market on March 04, 2014, following the approval by the United States Food & Drug Administration (US FDA).
The Avelox (moxifloxacin HCl) tablets brand had US sales of approximately $195 million for the most recent twelve months ending in December 2013 according to IMS Health.
Dr Reddy’s moxifloxacin hydrochloride tablets, 400 mg is available in bottle counts of 30.
EP News Bureau – Mumbai
- Advertisement -
